EL PAPEL TROMBOGENICO DE UN SISTEMA FIBRINOLITICO ANORMAL
Columnista Experta de SIIC Hau C. Kwaan
en colaboración con
Lisa N. Boggio, MD. , Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Chadi Nabhan, MD , Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
Primera edición en siicsalud:
7 de junio, 2005
Sección Artículos originales,
subsección
Expertos de Iberoamérica,
página
/des/expertocompleto.php/69188
Especialidad principal:
Hematología
Especialidades relacionadas:
Bioquímica,Diagnóstico por Laboratorio,Medicina Interna,
Zakarija A, Bandarenko N, Pandey DK, Auerbach A, Raisch DW, Kim B, Kwaan HC, McKoy JM, Schmitt BP, Davidson CJ, Yarnold PR, Gorelick PB, Bennett CL. Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration, Stroke 35(35):533-7
Ladewski LA, Belknap SM, Nebeker JR, Sartor O, Lyons EA, Kuzel TC, Tallman MS, Raisch DW, Auerbach AR, Schumock GT, Kwaan HC, Bennett CL. Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project, Journal of Clinical Oncology 21(21):3859-66
Zakarija A, Kwaan HC. Bleeding and thrombosis in the cancer patient, Expert Review of Cardiovascular Therapy 1(1):271-81
Kwaan HC, Parmar S, Wang J. Pathogenesis of increased risk of thrombosis in cancer, Seminars in Thrombosis & Hemostasis 29(29):283-90
Hau C. Kwaan
